In the pediatric population, it has been reported that 14% of pediatric hypertrophic cardiomyopathy cases are caused by compound heterozygous variants in MYBPC3, which occur when both copies of a particular gene each carry a mutation (not necessarily the same mutation) [10]. Here, MYBPC3 is linked to hypertrophic cardiomyopathy.